Herskovic V, Jacard M, Reyes H
Facultad de Medicina (Campus Oriente), Universidad de Chile, Santiago de Chile.
Rev Med Chil. 2000 Apr;128(4):411-8.
Molecular biology is a new branch of biological sciences, with novel laboratory techniques that are being progressively applied into biomedical and clinical research and, furthermore, into medical practice.
To evaluate the use of molecular biology techniques in Chilean biomedical and clinical research and its evolution in the recent decade.
All papers published as research articles, clinical experiences or case reports, in Revista Médica de Chile, during two time periods: 1987-1989 and 1997-1999, were reviewed to find out whether molecular biology techniques had been used or not. This journal publishes roughly 40% of papers generated in Chile, in biomedical or clinical topics, while another 15% appears in foreign journals.
Among 341 papers published in 1987-1989, 57 (16.7%) had used one or more molecular biology techniques; in contrast, among 318 papers published in 1997-1999, 91 (28.8%) had used them (p < 0.001). Most papers using molecular biology techniques were research articles. Immunology, genetics, endocrinology, hematology, hepatology and rheumatology were the specialties providing a greater number and proportion of papers using molecular biology techniques. Chilean universities were the main institutions sponsoring these articles and FONDECYT (the Chilean Government Research Granting Office) was the main source of funding. The University of Chile (State-owned) provided most centers where these publications had been generated, followed by the Pontifical Catholic University of Chile.
Molecular biology techniques have been rapidly and progressively incorporated as research tools in biomedicine and clinical medicine, in Chile. At the present time, these techniques are predominantly used in research conducted in University settings and funded by Governmental research grants.
分子生物学是生物科学的一个新分支,其新颖的实验室技术正逐渐应用于生物医学和临床研究,进而应用于医疗实践。
评估分子生物学技术在智利生物医学和临床研究中的应用情况及其近十年的发展。
对《智利医学杂志》在两个时间段(1987 - 1989年和1997 - 1999年)发表的所有研究论文、临床经验或病例报告进行审查,以确定是否使用了分子生物学技术。该杂志发表了智利产生的约40%的生物医学或临床主题论文,另有15%发表在国外期刊上。
在1987 - 1989年发表的341篇论文中,57篇(16.7%)使用了一种或多种分子生物学技术;相比之下,在1997 - 1999年发表的318篇论文中,91篇(28.8%)使用了这些技术(p < 0.001)。大多数使用分子生物学技术的论文是研究论文。免疫学、遗传学、内分泌学、血液学、肝病学和风湿病学是使用分子生物学技术的论文数量和比例较高的专业领域。智利的大学是资助这些文章的主要机构,而智利国家科学技术研究委员会(FONDECYT,智利政府研究资助办公室)是主要的资金来源。智利大学(国立)提供了产生这些出版物的大多数中心,其次是智利天主教大学。
在智利,分子生物学技术已迅速且逐渐被纳入生物医学和临床医学的研究工具中。目前,这些技术主要用于大学环境中开展的、由政府研究资助的研究。